RedHill Biopharma
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8311 Brier Creek Pkwy Ste 105-161, Ralei...Phone Number
(984) 444-7010Website
www.redhillbio.comRevenue
$9.6 MillionStock Symbol
RDHLIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About RedHill Biopharma
Founded in 2009, RedHill Biopharma is a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. The company is headquartered in Tel Aviv, Isreal.Explore more
RedHill Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RedHill Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if RedHill Biopharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once RedHill Biopharma has new funding data
Earning: See what the market has to say on RedHill Biopharma recently announced quarterly report
Check out if RedHill Biopharma is spiking on competitors!
Click to see if RedHill Biopharma had a recent Job posting/layoffs
RedHill Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at RedHill Biopharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when RedHill Biopharma launches new products
Recommended Actions
Reach out to Masked Content who joined RedHill Biopharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
RedHill Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RedHill Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RedHill Biopharma.
RedHill Biopharma financials insights
Gather financial insights about RedHill Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$2M
RedHill Biopharma Tech Stack
A closer look at the technologies used by RedHill Biopharma
See more technologies
Most Recent Scoops
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Lawsuits, Legal Affairs
Person-Based
Person-Based
Pharmaceuticals
Person-Based
Pharmaceuticals
RedHill Biopharma News & Media
Redhill Biopharma Stock Doubles In One Session — Here's Why
Redhill Biopharma Ltd. (NASDAQ:RDHL) shares are up on Monday as investors react to the company’s divestment of Talicia and the cash-and-milestones structure tied to that deal. RDHL Stock Jumps After Talicia Divestment To Apotex Redhill says it is divesting Talicia to Apotex for $18 million in upfront cash plus additional milestone payments, framing the move as a key step in its strategic roadmap to reposition its commercial business toward larger product opportunities and revenue growth.RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities
Executes a major step in RedHill's strategic roadmap to fundamentally reposition the Company's commercial business toward new and larger product opportunities, revenue growth and an accelerated path toward operational profitability -- Realizes substantial value from RedHill's 70% stake in...Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development
The number of confirmed Ebola cases and deaths has increased substantially to 3221 cases and 1407 deaths -- Finalization of development next steps and potential partnership discussions ongoing, including with the Emergency Task Force expert group of the African Medicines Agency, the...RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
$6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon the exercise in full of warrants TEL AVIV, Israel and RALEIGH, N.C., June 22, 2026 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RedHill Biopharma
Sign Up For FreeTo access detailed company insights
Founded in 2009, RedHill Biopharma is a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo... Read More
